Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Bioequivalent Pharmaceutical Composition Of Apixaban And One Or More Pharmaceutically Acceptable Excipients.
Abstract: The present invention relates to a stable, reproducible and bioequivalent pharmaceutical composition comprising Apixaban having D90 more than 100 u, more preferably more than 300p-t0 1000p and most preferably more than 350}; to 800p and one or more pharmaceutically acceptable excipient, a wet granulation process for preparation of the pharmaceutical composition comprising Apixaban is also provided.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
17 February 2017
Publication Number
34/2018
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
ipm@unichemlabs.com
Parent Application
Applicants
UNICHEM LABORATORIES LTD
UNICHEM BHAVAN, PRABHAT ESTATE,OFF S. V. ROAD, JOGESHWARI (WEST), MUMBAI-400 102, MAHARASHTRA, INDIA.
Inventors
1. MR. MILIND VINAYAK SATHE
LAXMI NIWAS CHS,FLAT NO 42 OFF SUBHASH ROAD PLOT NO 22,VILE PARLE(EAST) MUMBAI-400057,MAHARASHTRA INDIA.
2. MR SRIKANT V PIMPLE
B101,VASTUSHREE PEARL NEAR KINARA HOTEL,PAUD ROAD,KOTHRUD PUNE-411038,MAHARASHTRA INDIA.
3. MR PRAVIN KUMAR MAURYA
SURVEY NO.139/3 FLAT NO.112,1ST FLOOR AQUAMARINA SHINDE WASTI ROAD,BEHIND ESCON TEMPLE,RAVET,KIVALE PUNE-412101,MAHARASHTRA INDIA.
4. MR DHANANJAY PRAMOD TATTU
AT POST-PATAS TALUKA-DAUND DISTRICT-PUNE MAHARASHTRA-412219,INDIA.
Specification
Documents
Orders
| Section | Controller | Decision Date |
|---|---|---|
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201721005628-Correspondence to notify the Controller [11-09-2023(online)].pdf | 2023-09-11 |
| 1 | 201721005628-FORM-26 [21-02-2018(online)].pdf | 2018-02-21 |
| 2 | 201721005628-REQUEST FOR CERTIFIED COPY [30-03-2018(online)].pdf | 2018-03-30 |
| 2 | 201721005628-US(14)-HearingNotice-(HearingDate-15-09-2023).pdf | 2023-08-25 |
| 3 | 201721005628-Response to office action (Mandatory) [04-04-2018(online)].pdf | 2018-04-04 |
| 3 | 201721005628-FORM 3 [29-04-2023(online)].pdf | 2023-04-29 |
| 4 | 201721005628-FORM 3 [01-11-2022(online)].pdf | 2022-11-01 |
| 4 | 201721005628-CORRESPONDENCE(IPO)-(CERTIFIED COPY)-(05-04-2018).pdf | 2018-04-05 |
| 5 | 201721005628-Other Patent Document-170217.pdf | 2018-08-11 |
| 5 | 201721005628-FORM 3 [03-05-2022(online)].pdf | 2022-05-03 |
| 6 | 201721005628-ORIGINAL UNDER RULE 6 (1A)-FORM 26-260218.pdf | 2018-08-11 |
| 6 | 201721005628-FORM 13 [29-10-2021(online)].pdf | 2021-10-29 |
| 7 | 201721005628-Form 5-170217.pdf | 2018-08-11 |
| 7 | 201721005628-FER.pdf | 2021-10-18 |
| 8 | 201721005628-Form 3-170217.pdf | 2018-08-11 |
| 8 | 201721005628-FER_SER_REPLY [09-09-2021(online)].pdf | 2021-09-09 |
| 9 | 201721005628-FORM 3 [23-02-2021(online)].pdf | 2021-02-23 |
| 9 | 201721005628-Form 3-140218.pdf | 2018-08-11 |
| 10 | 201721005628-FORM 18 [29-01-2021(online)].pdf | 2021-01-29 |
| 10 | 201721005628-Form 2(Title Page)-170217.pdf | 2018-08-11 |
| 11 | 201721005628-Form 1-170217.pdf | 2018-08-11 |
| 11 | 201721005628-FORM 3 [28-07-2020(online)].pdf | 2020-07-28 |
| 12 | 201721005628-Correspondence-181217.pdf | 2018-08-11 |
| 12 | 201721005628-FORM 3 [25-02-2020(online)].pdf | 2020-02-25 |
| 13 | 201721005628-FORM 3 [17-08-2018(online)].pdf | 2018-08-17 |
| 13 | 201721005628-Form 3-010319.pdf | 2020-01-14 |
| 14 | 201721005628-Correspondence-300719.pdf | 2019-08-01 |
| 14 | 201721005628-Form 3-040919.pdf | 2019-11-02 |
| 15 | 201721005628-FORM 3 [27-08-2019(online)].pdf | 2019-08-27 |
| 16 | 201721005628-Correspondence-300719.pdf | 2019-08-01 |
| 16 | 201721005628-Form 3-040919.pdf | 2019-11-02 |
| 17 | 201721005628-Form 3-010319.pdf | 2020-01-14 |
| 17 | 201721005628-FORM 3 [17-08-2018(online)].pdf | 2018-08-17 |
| 18 | 201721005628-FORM 3 [25-02-2020(online)].pdf | 2020-02-25 |
| 18 | 201721005628-Correspondence-181217.pdf | 2018-08-11 |
| 19 | 201721005628-Form 1-170217.pdf | 2018-08-11 |
| 19 | 201721005628-FORM 3 [28-07-2020(online)].pdf | 2020-07-28 |
| 20 | 201721005628-FORM 18 [29-01-2021(online)].pdf | 2021-01-29 |
| 20 | 201721005628-Form 2(Title Page)-170217.pdf | 2018-08-11 |
| 21 | 201721005628-FORM 3 [23-02-2021(online)].pdf | 2021-02-23 |
| 21 | 201721005628-Form 3-140218.pdf | 2018-08-11 |
| 22 | 201721005628-FER_SER_REPLY [09-09-2021(online)].pdf | 2021-09-09 |
| 22 | 201721005628-Form 3-170217.pdf | 2018-08-11 |
| 23 | 201721005628-FER.pdf | 2021-10-18 |
| 23 | 201721005628-Form 5-170217.pdf | 2018-08-11 |
| 24 | 201721005628-FORM 13 [29-10-2021(online)].pdf | 2021-10-29 |
| 24 | 201721005628-ORIGINAL UNDER RULE 6 (1A)-FORM 26-260218.pdf | 2018-08-11 |
| 25 | 201721005628-Other Patent Document-170217.pdf | 2018-08-11 |
| 25 | 201721005628-FORM 3 [03-05-2022(online)].pdf | 2022-05-03 |
| 26 | 201721005628-FORM 3 [01-11-2022(online)].pdf | 2022-11-01 |
| 26 | 201721005628-CORRESPONDENCE(IPO)-(CERTIFIED COPY)-(05-04-2018).pdf | 2018-04-05 |
| 27 | 201721005628-Response to office action (Mandatory) [04-04-2018(online)].pdf | 2018-04-04 |
| 27 | 201721005628-FORM 3 [29-04-2023(online)].pdf | 2023-04-29 |
| 28 | 201721005628-US(14)-HearingNotice-(HearingDate-15-09-2023).pdf | 2023-08-25 |
| 28 | 201721005628-REQUEST FOR CERTIFIED COPY [30-03-2018(online)].pdf | 2018-03-30 |
| 29 | 201721005628-FORM-26 [21-02-2018(online)].pdf | 2018-02-21 |
| 29 | 201721005628-Correspondence to notify the Controller [11-09-2023(online)].pdf | 2023-09-11 |
Search Strategy
| 1 | SearchStrategyE_19-03-2021.pdf |